ANIKA THERAPEUTICS INC (ANIK) Stock Earnings & Estimates
USA - NASDAQ:ANIK - US0352551081 - Common Stock
8.67 USD
+0.04 (+0.46%)
8.67 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 156.2M 5.68% | 120.792M -22.67% | 119.907M -0.73% | 113.21M -5.59% | 119.26M 5.34% | 129.19M 8.33% | 240.01M 85.78% | |
| EBITDA YoY % growth | -4.92M -129.08% | 18.094M 467.76% | 5.811M -67.88% | 773.67K -86.69% | 5.902M 662.86% | 11.984M 103.05% | 50.898M 324.72% | |
| EBIT YoY % growth | -19.4M -846.15% | 3.877M 119.98% | -2.31M -159.58% | -14.86M -543.28% | -12.024M 19.08% | -8.11M 32.55% | 19.584M 341.48% | |
| Operating Margin | -12.42% | 3.21% | -1.93% | -13.13% | -10.08% | -6.28% | 8.16% | |
| EPS YoY % growth | -0.89 -406.90% | -5.41 -507.87% | -2.07 61.74% | -1.16 43.83% | -0.38 66.96% | -0.02 94.69% | 1.46 7,250.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 -8.80% | -0.22 85.49% | -0.23 31.00% | -0.18 35.64% | -0.16 42.50% | -0.03 85.94% |
| Revenue Q2Q % growth | 28.084M -27.53% | 29.648M -3.12% | 28.464M 8.77% | 29.919M 6.02% | 29.687M 5.71% | 30.52M 2.94% |
| EBITDA Q2Q % growth | 698.7K -84.67% | 1.305M -82.40% | 402.9K 114.97% | 1.382M 217.92% | 1.794M 156.76% | 2.323M 78.01% |
| EBIT Q2Q % growth | -3.407M -94.56% | -2.801M -296.80% | -3.983M 7.02% | -3.004M 28.14% | -2.796M 17.92% | -2.354M 15.98% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.28 -2,700.00% | -0.26 | -0.02 | -8.36% |
| Q1 2025 Q2Q % growth | -0.34 -9.68% | -0.15 | -0.19 | -132.56% |
| Q4 2024 Q2Q % growth | -1.50 65.12% | -0.30 | -1.20 | -398.50% |
| Q3 2024 Q2Q % growth | -0.25 44.44% | -0.02 | -0.23 | -1,533.99% |
| Q2 2024 Q2Q % growth | -0.01 94.74% | 0.05 | -0.06 | -121.01% |
| Q1 2024 Q2Q % growth | -0.31 34.04% | -0.19 | -0.12 | -62.81% |
| Q4 2023 Q2Q % growth | -4.30 -1,164.71% | -0.27 | -4.03 | -1,500.91% |
| Q3 2023 Q2Q % growth | -0.45 -200.00% | -0.38 | -0.07 | -18.17% |
| Q2 2023 Q2Q % growth | -0.19 5.00% | -0.28 | 0.09 | 31.01% |
| Q1 2023 Q2Q % growth | -0.47 -135.00% | -0.31 | -0.16 | -53.59% |
| Q4 2022 Q2Q % growth | -0.34 15.00% | -0.24 | -0.10 | -38.89% |
| Q3 2022 Q2Q % growth | -0.15 -475.00% | -0.26 | 0.11 | 41.18% |
| Q2 2022 Q2Q % growth | -0.20 -144.44% | -0.23 | 0.03 | 13.50% |
| Q1 2022 Q2Q % growth | -0.20 -200.00% | -0.37 | 0.17 | 46.28% |
| Q4 2021 Q2Q % growth | -0.40 -433.33% | -0.26 | -0.14 | -55.31% |
| Q3 2021 Q2Q % growth | 0.04 108.89% | -0.21 | 0.25 | 118.67% |
| Q2 2021 Q2Q % growth | 0.45 221.62% | -0.15 | 0.60 | 400.80% |
| Q1 2021 Q2Q % growth | 0.20 233.33% | -0.13 | 0.33 | 256.86% |
| Q4 2020 Q2Q % growth | 0.12 -72.09% | 0.14 | -0.02 | -15.97% |
| Q3 2020 Q2Q % growth | -0.45 -170.31% | -0.01 | -0.44 | -4,311.76% |
| Q2 2020 Q2Q % growth | -0.37 -154.41% | -0.25 | -0.12 | -48.06% |
| Q1 2020 Q2Q % growth | 0.06 -80.65% | -0.07 | 0.13 | 190.50% |
| Q4 2019 Q2Q % growth | 0.43 | 0.43 | 0.00 | 1.18% |
| Q3 2019 Q2Q % growth | 0.64 | 0.40 | 0.24 | 59.52% |
| Q2 2019 Q2Q % growth | 0.68 | 0.40 | 0.28 | 72.04% |
| Q1 2019 Q2Q % growth | 0.31 | 0.20 | 0.11 | 57.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 28.219M -32.69% | 27.574M | 645K | 2.34% |
| Q1 2025 Q2Q % growth | 26.168M -35.42% | 28.628M | -2.46M | -8.59% |
| Q4 2024 Q2Q % growth | 30.602M -28.78% | 29.58M | 1.022M | 3.46% |
| Q3 2024 Q2Q % growth | 38.753M -6.54% | 42.924M | -4.171M | -9.72% |
| Q2 2024 Q2Q % growth | 41.921M -5.37% | 42.941M | -1.02M | -2.38% |
| Q1 2024 Q2Q % growth | 40.523M 6.85% | 39.926M | 597K | 1.50% |
| Q4 2023 Q2Q % growth | 42.971M 8.46% | 42.233M | 738K | 1.75% |
| Q3 2023 Q2Q % growth | 41.465M 2.99% | 39.031M | 2.434M | 6.24% |
| Q2 2023 Q2Q % growth | 44.302M 11.70% | 41.368M | 2.934M | 7.09% |
| Q1 2023 Q2Q % growth | 37.924M 3.36% | 38.026M | -102K | -0.27% |
| Q4 2022 Q2Q % growth | 39.62M 10.61% | 38.459M | 1.161M | 3.02% |
| Q3 2022 Q2Q % growth | 40.26M 1.82% | 38.337M | 1.923M | 5.02% |
| Q2 2022 Q2Q % growth | 39.66M 3.96% | 38.609M | 1.051M | 2.72% |
| Q1 2022 Q2Q % growth | 36.69M 7.00% | 33.557M | 3.133M | 9.34% |
| Q4 2021 Q2Q % growth | 35.82M 9.57% | 32.693M | 3.127M | 9.56% |
| Q3 2021 Q2Q % growth | 39.54M 24.77% | 37.044M | 2.496M | 6.74% |
| Q2 2021 Q2Q % growth | 38.15M 24.35% | 35.196M | 2.954M | 8.39% |
| Q1 2021 Q2Q % growth | 34.29M -3.14% | 32.841M | 1.449M | 4.41% |
| Q4 2020 Q2Q % growth | 32.69M 9.81% | 34.17M | -1.48M | -4.33% |
| Q3 2020 Q2Q % growth | 31.69M 6.70% | 30.716M | 974K | 3.17% |
| Q2 2020 Q2Q % growth | 30.68M 0.85% | 20.775M | 9.905M | 47.68% |
| Q1 2020 Q2Q % growth | 35.4M 43.20% | 32.163M | 3.237M | 10.06% |
| Q4 2019 Q2Q % growth | 29.77M | 28.121M | 1.649M | 5.86% |
| Q3 2019 Q2Q % growth | 29.7M | 27.552M | 2.148M | 7.80% |
| Q2 2019 Q2Q % growth | 30.42M | 28.055M | 2.365M | 8.43% |
| Q1 2019 Q2Q % growth | 24.72M | 22.322M | 2.398M | 10.74% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.44% | -42.86% | -3.64% | -35.71% |
| Revenue | 0% | 0.36% | 0.94% | 0.94% |